Arkolith/Insider Trading/SLRX/Form 4

Arthur David J.

Chief Executive Officer, DirectorSalarius Pharmaceuticals, Inc. (SLRX) · full profile →Form 4 · filed May 31, 2022
Net Buying
Open-Market Buys
$8K
Open-Market Sells
$0
Net Open-Market Flow
$8K
Transactions
5
5 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 26, 2022Buy(P)10K$0.18$2K293K
May 26, 2022Buy(P)11K$0.18$2K304K
May 26, 2022Buy(P)3K$0.18$612263K
May 26, 2022Buy(P)19K$0.18$3K282K
May 26, 2022Buy(P)708$0.18$127282K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001615219-22-000087) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML